Prudential Financial, Inc. (PRU) is currently trading at $118.85. Based on 15 Wall Street analysts, the average target price is $105.07, implying a 11.6% downside. The consensus recommendation is HOLD.

PRU

Prudential Financial, Inc.

FinancialsOpinion: hold

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$118.85

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

No price target figures in the last 3 months of upgrade/downgrade history—range cannot be shown.

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Recent price target updates (latest 80)

No recent price target changes are available in the data feed.

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$105.07

Based on 15 analysts

Analyst Recommendations

Buy (0)Hold (13)Sell (5)

Upside

-11.60%

Market Cap

$0.00B

Financial & Investment Metrics

P/E Ratio (TTM)12.24
Forward P/E8.16
P/B RatioN/A
Dividend Yield4.72%
Return on Equity (ROE)10.71%
Operating Margin4.72%
Debt to Equity158.97
Beta (Volatility)0.84
52 Week Range$91.89 - $120.58
LowCurrent: $118.85High

Latest News

Daily editorial mentioning PRU

Price target moves

Healthcare and Energy Dominate July 10 Price Target Revisions

As of the morning of July 10, 2026, the desks have been busy processing a wave of target adjustments across the S&P 500. While the volume of revisions remains elevated, sector-specific sentiment appears to be pulling in competing directions, particularly within the energy and healthcare spaces.

* RBC Capital was particularly active, lifting targets across UNH, ELV, and CVS. * Energy names like DVN and AR faced downward revisions from Truist Securities. * Goldman Sachs signaled a significant adjustment for NOW, lowering the target to 145.

Notable adjustments

The movement in the healthcare sector was sharp. RBC Capital pushed UnitedHealth (UNH) from 400 to 463, while Elevance Health (ELV) saw a move from 358 to 439. CVS Health (CVS) also saw a modest lift to 113 from 107. These adjustments arrive despite a broader caution elsewhere; for instance, Piper Sandler’s subtle trim to Regeneron (REGN), moving it from 855 to 854, suggests some analysts are finding limited room for further upside in high-priced biopharma.

In the energy patch, the outlook has taken a more defensive turn. Citigroup dialed back EOG Resources (EOG) to 141 from 147, and Truist Securities lowered its expectations for both Devon Energy (DVN) and Antero Resources (AR). DVN dropped from 66 to 61, while AR shifted from 56 to 52. These downward revisions contrast with the optimism seen in other corners of the market, such as UBS pushing TSLA up to 442 from 364.

Broader watchlist context

Financials were a mixed bag of activity. Wells Fargo opted to boost the targets for MetLife (MET) and Chubb (CB), moving them to 101 and 358 respectively, while simultaneously trimming Aon (AON) to 406. Perhaps most telling was the shift in sentiment toward Intercontinental Exchange (ICE), which Barclays moved down to 180 from 201.

The materials sector also saw some cooling. Goldman Sachs lowered Freeport-McMoRan (FCX) to 74 from 75, and RBC Capital reduced its target for Newmont (NEM) to 135 from 140. For a complete view of how these shifts compare to historical trends, see the full moves database. The disparity between these downward adjustments and the more aggressive moves in industrials—where GE was lifted to 430 by Susquehanna—highlights the fragmented nature of current analyst sentiment.

Read article

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 4Insider Sells: 6

Whale Trades (C-Level Large Buys)

Major insider buying detected recently.

STODDARD THOMAS D (Director) - 250 shares

Recent Insider Transactions

DateNamePositionTransactionShares
5/14/2026KAPPLER ANN MGeneral CounselSale at price 103.25 per share.13,580
2/17/2026STODDARD THOMAS DDirectorPurchase at price 102.97 per share.250
2/11/2026WOLK JOSEPH JDirectorPurchase at price 105.32 per share.400
2/6/2026CHAPPUIS JACQUES POfficerPurchase at price 100.97 per share.1,000
12/11/2025FEENEY CAROLINEOfficerSale at price 116.28 per share.6,555
12/2/2025SCHMIDT TIMOTHY LOfficerSale at price 107.69 per share.8,000
11/10/2025LOWREY CHARLES FChairman of the BoardSale at price 107.39 per share.48,164
8/29/2025KAPPLER ANN MGeneral CounselSale at price 109.65 per share.4,000
3/12/2025SULLIVAN ANDREW FOfficerSale at price 105.98 per share.6,000
2/20/2025DI SIBIO CARMINEDirectorPurchase at price 111.04 per share.200

Frequently Asked Questions

Q. What is the current target price and upside for PRU?

A. The current target price for Prudential Financial, Inc. is $105.07, which implies a 11.6% downside from the current price of $118.85. This is based on the consensus of 15 Wall Street analysts.

Q. What is the current analyst recommendation for PRU?

A. Currently, there are 0 Strong Buy, 0 Buy, 13 Hold, 3 Sell, and 2 Strong Sell ratings. The overall consensus is HOLD.

Q. Are insiders buying PRU stock recently?

A. Over the past 6 months, there have been 4 insider buys and 6 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Financials

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer